Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and age-related muscular degeneration (Armd). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Romainville, FR
Size (employees)
10 (est)
Biophytis was founded in 2006 and is headquartered in Romainville, FR
Report incorrect company information

Biophytis Office Locations

Biophytis has an office in Romainville
Romainville, FR (HQ)
102, avenue Gaston Roussel
Show all (1)
Report incorrect company information

Biophytis Financials and Metrics

Biophytis Financials

Market capitalization (31-Oct-2017)

35.3 m

Closing share price (31-Oct-2017)

Biophytis's current market capitalization is €35.3 m.
Show all financial metrics
Report incorrect company information